Harmonization of antimicrobial breakpoints in Europe - Can it be achieved?

Clinical Microbiology Newsletter

Volumn 26, Issue 24, 2004, Pages 187-192

  Kahlmeter, Gunnar ^a   Brown, Derek F J ^b  

^a CENTRAL HOSPITAL   (Sweden)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; LINEZOLID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; EUROPE; MINIMUM INHIBITORY CONCENTRATION; REVIEW; WILD TYPE;

EID: 12444341823     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0196-4399(04)80015-1     Document Type: Review

References (21)

1. updates on MacGowan A.P., and R. Wise Establishing MIC breakpoints and interpretation of in vitro susceptibility tests J. Antimicrob. Chemother. 48 Suppl. S1 2001 17 28
2. Updates on SFM Antibiogram Committee Comité de l'Antibiogramme de la Société Française de Microbiologie Report 2003 Int. J. Antimicrob. Agents 21 2003 364 391
3. Commissie Richtlijnen Gevoeligheidsbepalingen Interpretatie van gevoeligheidsonderzoek en gevoeligheidscriteria voor antibacteriële middelen in Nederland Ned. Tijdschr. Med. Microbiol. 3 2000 79 81
4. Deutsches Institut für Normung Medical Microbiology -- susceptibility testing of pathogens to antimicrobial agents 1999 DIN 58940 58944
5. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Approved Standard M7-A6 6th ed. 2003 NCCLS Berlin
6. (Suppl) Bergan T. Susceptibility testing of bacteria and fungi Scand. J. Infect. Dis. 103 1997 1 36
7. Updates on Swedish Reference Group of Antibiotics^ Antimicrobial susceptibility testing in Sweden Scand. J. Infect. Dis. Suppl. 105 1997 5 31
8. European Committee on Antimicrobial Susceptibility Testing Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. EUCAST Definitive Document E.Def 1.2 Clin. Microbiol. Infect. 6 2000 503 508
9. European Committee on Antimicrobial Susceptibility Testing Determination of antimicrobial susceptibility test breakpoints. EUCAST Definitive Document E.Def 2.1 Clin. Microbiol. Infect. 6 2000 570 572
10. European Committee on Antimicrobial Susceptibility Testing Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. EUCAST Definitive Document E.Def 3.1 Clin. Microbiol. Infect. 6 2000 509 515
11. European Committee on Antimicrobial Susceptibility Testing Linezolid breakpoints. EUCAST Definitive Document E.Def 4.1 Clin. Microbiol. Infect. 7 2001 283 284
12. (issue 8 insert) European Committee on Antimicrobial Susceptibility Testing Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth microdilution. EUCAST Discussion Document E.Def 5.1 Clin. Microbiol. Infect. 9 2003 1 7
13. (issue 12 insert) Ridgway G.L. Antimicrobial susceptibility testing of intracellular and cell-associated pathogens. EUCAST Discussion Document E.Dis 6.1 Clin. Microbiol. Infect. 7 2001 1 10
14. (issue 10 insert) Drobniewski F. Antimicrobial susceptibility testing of Mycobacterium tuberculosis. EUCAST Discussion Document E.Dis 8.1 Clin. Microbiol. Infect. 8 2002 1 10
15. (issue 8 insert) Rodriguez-Tudela J.L. Determination of minimum inhibitory concentrations by broth microdilution of fermentative yeasts. EUCAST Discussion Document E.Dis 7.1 Clin. Microbiol. Infect. 9 2003 1 8
16. (suppl) Ringertz S. Antimicrobial susceptibility testing in Sweden II. Species-related zone diameter breakpoints to avoid interpretive errors and guard againstunrecognized evolution of resistance Scand. J. Infect. Dis. 105 1997 8 12
17. Kahlmeter G. European harmonisation of MIC breakpoints for antimicrobial susceptibility testing of bacteria J. Antimicrob. Chemother. 52 2003 145 148
18. abstr. S273 Kahlmeter G., and N. Bruinsma Antimicrobial resistance frequencies using EUCAST epidemiological cut-off values compared with national breakpoints when applied to the EARSSdatabase Abstracts of the 14th European Congress of Clinical Microbiology and Infectious Diseases Prague 2004
19. Daily P. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae -- United States, 2003 Morb. Mortal. Wkly. Rep. 53 2004 152 154
20. Mouton J.W. Impact of pharmacodynamics on breakpoint selection for susceptibility testing Infect. Dis. Clin. N. Am. 17 2003 579 598
21. Kronvall G. New method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes Clin. Microbiol. Infect. 9 2003 120 132